REDHILL BIOPHARMA LTD-SP ADR (RDHL)
US7574683014 - ADR
REDHILL BIOPHARMA LTD-SP ADR
NASDAQ:RDHL (1/14/2025, 8:02:11 PM)
5.506
-0.07 (-1.22%)
Company Profile
Redhill Biopharma Ltd is a IL-based company operating in Pharmaceuticals industry. RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.
Company Info
REDHILL BIOPHARMA LTD-SP ADR
21 Ha'arba'a St.
TEL AVIV-YAFO 64739
P: 97235413131
CEO: Dror Ben-Asher
Employees: 53
Website: https://www.redhillbio.com/
RDHL News
a month ago - RedHill Biopharma Ltd.Radioprotective Activity of RedHill's Opaganib for GI-ARS Confirmed in New RNCP/NIAID Study - Discussions Ongoing with U.S. Government on Advanced DevelopmentHeightened geopolitical tensions and Homeland Security concerns call for the development of potential therapies that can be quickly and easily mobilized in the...
a month ago - RedHill Biopharma Ltd.RedHill Biopharma Awarded Judgment of Approximately $8 Million Plus Costs by New York Supreme Court/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the Company has...
2 months ago - Actinium Pharmaceuticals, Inc.Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of Antibody Radiation Conjugates...
3 months ago - RedHill Biopharma Ltd.RedHill Selected to Present Opaganib at Conference Organized by U.S. Government's JPEO-CBRNDRedHill has been selected to provide a presentation to further elaborate on opaganib's potential to U.S. government representatives at the Joint Program...
3 months ago - RedHill Biopharma Ltd.RedHill Announces Collaboration with a Leading U.S. Academic Medical Center to Develop Opaganib as a Countermeasure Against Phosgene Inhalation InjuryThe collaboration outlines plans for multiple in vivo studies, designed to test opaganib as a potential medical countermeasure to treat phosgene inhalation...
3 months ago - RedHill Biopharma Ltd.RedHill Biopharma Secures U.S. Government Funding through BARDA to Advance Opaganib for Ebola TreatmentThe U.S. government's Biomedical Advanced Research and Development Authority (BARDA) selected opaganib for joint development & funding as a medical...
RDHL Twits
Here you can normally see the latest stock twits on RDHL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
